- About this researcher
Lianbo Yu
Associate Professor
Biomedical Informatics
Academic information
- Department: Biomedical Informatics
Research interests
- NGS data
- CRISPR Screening Data Modeling
About
Biography
I am currently a clinical associate professor in the Department of Biomedical Informatics at The Ohio State University. I am also the high-dimensional group leader in the Center for Biostatistics, where I collaborate with investigators from College of Medicine and Comprehensive Cancer Center. I also serve as the Director of Biostatistics Core for multiple NCI program project grant awards and applications. My research focus is to answer genomic-based biological questions by utilizing high-throughput genomic data. I am currently interested in variance smoothing for testing differential expression in NGS data, sample size calculation for NGS data, data integration of multiple genotypes and multiple platforms, predictive model with biomarkers, CRISPR screening data modeling.
I earned both my master of science and doctoral degrees in Statistics at Purdue University, where my research focused on developing advanced statistical methods for high-throughput proteomic data. I joined the Center for Biostatistics at OSU in 2006 and the Department of Biomedical Informatics in 2014.
Credentials
Education
- PhD - Statistics
- Purdue University, West Lafayette, IN, United States
- MSc - Statistics
- Purdue University, West Lafayette, IN, United States
- BS - Statistics
- Nankai University, Tianjin, China
Research
Research interests
- NGS data
- CRISPR Screening Data Modeling
More about my research
News and media
My news coverage
- $7.8 million federal award funds Alzheimer's research resource network
- Genomic Study Points to New Treatment Approaches for Advanced Small-Cell Lung Cancer
- $9.1 Million NCI Grant Renewal Will Support Cancer Retrovirus Research
- Ohio State Cancer Researchers Learn How Resistance Develops in a Lethal Bile Duct Cancer With Novel FGFR Inhibitor
- Experimental Blood Test Accurately Spots Fibromyalgia
- Genomic Analysis Is Important Even for Ultra-Hypermutated Tumors Prior to Immune Therapy
- New Drug Harnesses Immune System to Stop Triple-Negative Breast Cancer
- Ohio State Cancer Researchers Validate a Clinical Test For Fusion Genes
- Study Identifies How Cancer Cells May Develop Resistance to FGFR Inhibitors
- Loss of Tiny Liver Molecule Might Lead to Liver Cancer
- Marker Distinguishes More-Aggressive From Less-Aggressive Forms Of Chronic Leukemia
- Cancer Cells Send Out The Alarm On Tumor-Killing Virus
- Virus Might Fight Brain Tumors Better If Armed With Bacterial Enzyme Study Shows
- Early Immune Response Needed For Hit And Hide Cancer Virus
